LabGenius Therapeutics
PrivateLast Round
Series B
Extension
Feb 16, 2026
Total Funding Raised
$78.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
LabGenius Therapeutics is a biotechnology company that develops an AI-driven protein engineering platform to discover and optimize next-generation therapeutic antibodies for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LabGenius Therapeutics Comparables
Compare LabGenius Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BigHat Biosciences | 88% | |
| Generate Biomedicines | 83% | |
| AbCellera Biologics Inc. | 83% | |
LabGenius Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Feb 16, 2026 | ||||
| Series B | May 21, 2024 | ||||
| Grant | Nov 30, 2022 | ||||
| Grant | Oct 7, 2022 | ||||
| Series A Extension | Oct 29, 2020 | ||||
Series A | Oct 24, 2019 |
LabGenius Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Backed VC | Seed |
| System.One | Seed |
| Inovia Capital | Series A, Series A Extension |
| Air Street Capital | Series A |
| Acequia Capital | Seed |
| M Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 25, 2026
Monthly visitors increased 180% MoM, reaching 3.1K.
- Apr 17, 2026
Presenting preclinical data at AACR Annual Meeting 2026.
LabGenius Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LabGenius Therapeutics's valuation, stock price, and market status.